{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:28:06Z","timestamp":1751524086333},"reference-count":29,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.prostaglandins.2005.12.001","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T12:16:16Z","timestamp":1140869776000},"page":"199-205","source":"Crossref","is-referenced-by-count":4,"title":["Effect of misoprostol on bone mineral density in women with postmenopausal osteoporosis"],"prefix":"10.1016","volume":"79","author":[{"given":"Levent","family":"Yasar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali S\u00fcha","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurhan","family":"Utku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"\u00d6zcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziya","family":"\u00c7ebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadir","family":"Savan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necdet","family":"Sut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fehmi","family":"Yaz\u0131c\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prostaglandins.2005.12.001_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiology.170.3.2916037","article-title":"Appropriate use of bone densitometry","volume":"170","author":"Genant","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198606263142605","article-title":"Involutional osteoporosis","volume":"26","author":"Riggs","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-89-3-356","article-title":"Prevention of involutioual bone loss by exercise","volume":"89","author":"Abla","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib4","series-title":"Menopause. Novak's Gynecology","first-page":"1109","author":"Hurd","year":"2002"},{"issue":"7","key":"10.1016\/j.prostaglandins.2005.12.001_bib5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2106\/00004623-198466070-00007","article-title":"Bone loss in premenopausal and postmenopausal women- A cross-sectional and longitidunal study using quantitative CT","volume":"66","author":"Ruegsegger","year":"1984","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib6","doi-asserted-by":"crossref","unstructured":"Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial Writing Group for the Women's Health Initiative Investigators JAMA. 2002;288:321\u201333.","DOI":"10.1001\/jama.288.3.321"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib7","doi-asserted-by":"crossref","unstructured":"Kloosterboer HJ. Tissue-selectivity: the mechanism of action of tibolone. Maturitas 2004;48(Suppl. 1):30\u201340.","DOI":"10.1016\/j.maturitas.2004.02.012"},{"issue":"2","key":"10.1016\/j.prostaglandins.2005.12.001_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/jc.2004-1423","article-title":"Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone","volume":"90","author":"Hanifi-Moghaddam","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.prostaglandins.2005.12.001_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0968-0896(99)00045-0","article-title":"Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis","volume":"7","author":"Gil","year":"1999","journal-title":"Bioorg Med Chem"},{"issue":"9\u201310","key":"10.1016\/j.prostaglandins.2005.12.001_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-0714.1988.tb01324.x","article-title":"Local infusion of prostoglandin E1 stimulates mandibuler bone formation in vivo","volume":"17","author":"Marks","year":"1988","journal-title":"J Oral Pathol"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0090-6980(98)00080-X","article-title":"Effects of misoprostol on bone loss in ovariectomized rats","volume":"57","author":"S\u00f6nmez","year":"1999","journal-title":"Prostaglandins and other lipid mediators"},{"issue":"5","key":"10.1016\/j.prostaglandins.2005.12.001_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-3476(80)80282-4","article-title":"Cortical hyperostosis following long-term admistration of prostaglandin E1 infants with cyanotic congenital heart disease","volume":"97","author":"Ueda","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4615-0193-0_46","article-title":"The design and synthesis of selective prostaglandin analogs as bone anabolic agents for the potential treatment of osteoporosis","volume":"507","author":"Soper","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.prostaglandins.2005.12.001_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-6009(08)80230-9","article-title":"Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy","volume":"21","author":"Ke","year":"1993","journal-title":"Bone Miner"},{"issue":"3","key":"10.1016\/j.prostaglandins.2005.12.001_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S8756-3282(02)00835-9","article-title":"Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats","volume":"31","author":"Lomri","year":"2002","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.prostaglandins.2005.12.001_bib16","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1359\/jbmr.1997.12.12.2108","article-title":"Intermittent on\/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats","volume":"12","author":"Ma","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.prostaglandins.2005.12.001_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jor.1100140220","article-title":"Intraosseous infusion of prostaglandin E2 prevents disuse-induced bone loss in the tibia","volume":"14","author":"Welch","year":"1996","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.prostaglandins.2005.12.001_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jbmr.5650100111","article-title":"Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats","volume":"10","author":"Li","year":"1995","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.prostaglandins.2005.12.001_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jbmr.5650051110","article-title":"Prostaglandin E2 increased rat cortical bone mass when. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women","volume":"5","author":"Ke","year":"1990","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib20","unstructured":"Physicians Desk Reference. MontvaleNJ; Medical Economics Company, Inc.; 1993."},{"key":"10.1016\/j.prostaglandins.2005.12.001_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/8756-3282(94)90272-0","article-title":"Effects of prostoglandin E2 and risendronate administration on cancellous bone in older female rats","volume":"15","author":"Lin","year":"1994","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.prostaglandins.2005.12.001_bib22","first-page":"541","article-title":"Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone","volume":"31","author":"Reginster","year":"2002","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"3","key":"10.1016\/j.prostaglandins.2005.12.001_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-5122(03)00255-X","article-title":"The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis\u20148 years follow-up","volume":"47","author":"Prelevic","year":"2004","journal-title":"Maturitas"},{"issue":"10","key":"10.1016\/j.prostaglandins.2005.12.001_bib24","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jc.86.10.4717","article-title":"Prevention of bone loss with tibolon in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies","volume":"86","author":"Gallagher","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.prostaglandins.2005.12.001_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/cmt.5.4.390.398","article-title":"Ten years of treatment with tibolon 2.5mg daily: effects on bone loss in postmenopausal women","volume":"5","author":"Rymer","year":"2002","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.prostaglandins.2005.12.001_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1079\/BJN2001428","article-title":"Short- and long-term effects of calcium and exercise on bone mineral density in ovariectomized rats","volume":"86","author":"Gala","year":"2001","journal-title":"Br J Nutr"},{"issue":"5","key":"10.1016\/j.prostaglandins.2005.12.001_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1745-7599.1999.tb00562.x","article-title":"Supplemental and complementary alternatives to hormone replacement therapy","volume":"11","author":"Keller","year":"1999","journal-title":"J Am Acad Nurse Pract"},{"issue":"2","key":"10.1016\/j.prostaglandins.2005.12.001_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0749-0690(02)00073-3","article-title":"Calcium, vitamin D and nutrition in elderly adults","volume":"19","author":"Nieves","year":"2003","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"10.1016\/j.prostaglandins.2005.12.001_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5694\/j.1326-5377.2001.tb143554.x","article-title":"An open, crossover trial of calcium-fortified milk in prevention of early postmenopausal bone loss","volume":"175","author":"Cleghorn","year":"2001","journal-title":"Med J Aust"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882305001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T03:30:39Z","timestamp":1706931039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882305001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":29,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1098882305001437"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2005.12.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}